About the Drugs Monitoring Platform
The Drugs Monitoring Platform is a unique global online tool for collecting, monitoring and sharing a wide range of drug-related data and features an interactive online mapping resource.
The platform is managed by the Paris Pact Initiative, the Afghan Opiate Trade Project of the United Nations Office on Drugs and Crime (UNODC) and the UNODC Regional Office for Central Asia (ROCA).
The Drugs Monitoring Platform provides real-time information and analysis on the illicit global drug trade, including details on cultivation, production and trafficking. This information includes up-to-date drug and precursor seizure news, details of drug and precursor prices and data related to poppy cultivation in Afghanistan.
The Drugs Monitoring Platform (DMP) database holds a range of drugs related data. This data is either provided to the United Nations Office on Drugs and Crime (UNODC) by Member States or is obtained from media sources.
As the data provided to UNODC by Member States is considered restricted, access to the DMP can only be granted to certain user groups:
- Staff members of UNODC or other UN offices that research the impact of drug trafficking;
- Member State law enforcement organizations (local, national or federal police organizations);
- International police organizations (for example INTERPOL and EUROPOL);
- Member State government departments involved in drug related policy (for example Ministries of Interior, Ministries of Health, Ministries of Foreign Affairs and Embassies);
- Member State military units including military police and units involved in counter narcotics operations (for example Combined Maritime Forces);
- Supra-national government organizations with an interest in drug-related policy and research (for example CSTO, AU, SCO, NATO, EU);
- Government affiliated research organizations and training centres (for example Police staff colleges, government research centres).
Due to the restricted nature of some of the data on the Drugs Monitoring Platform, UNODC is unable to allow access to the following groups:
- Students and researchers at non-government sponsored academic institutions;
- Members of the public;
- Commercial companies;
- Individuals requesting registration with a personal email account (unless they have been verified).
Users of the Drugs Monitoring Platform agree not to share information from the system with groups who are not authorised to access the system